Fulgent Genetics (FLGT) Invested Capital (2020 - 2026)

Fulgent Genetics has disclosed Invested Capital across 7 years of filings, most recently posting $1.0 billion for Q2 2026.

• In Q2 2026, Invested Capital fell 9.92% year-over-year to $1.0 billion; the TTM figure through Jun 2026 stood at $1.0 billion (down 9.92% YoY), while the FY2025 annual figure was $1.1 billion, down 1.56% from the prior year.
• Invested Capital came in at $1.0 billion for Q2 2026 at Fulgent Genetics, down from $1.0 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.3 billion in Q1 2022 to a low of $1.0 billion in Q2 2026.
• Average Invested Capital over 5 years is $1.2 billion, with a median of $1.1 billion recorded in 2023.
• Year-over-year, Invested Capital surged 64.05% in 2022 and retreated 12.76% in 2024.
• Over 5 years, Invested Capital stood at $1.3 billion in 2022, then declined by 12.09% to $1.1 billion in 2023, then declined by 0.47% to $1.1 billion in 2024, then dropped by 1.56% to $1.1 billion in 2025, then fell by 9.95% to $1.0 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $1.0 billion in Q2 2026, $1.0 billion in Q1 2026, and $1.1 billion in Q4 2025.